Korea's leading vaccine makers face tougher competition

Domestic major hepatitis B vaccine makers, such as Korea Green Cross and LG Life Sciences, are desperately bracing for their R&D new product strategies in the wake of falling profit margins incurred more intense competition in the global vaccine tender market allowing new successful bidders such as CJ, let alone aggressive expansion of market share by vaccine makers from Ciba and India.

Curr...